Cell-penetrating peptides: strategies for anticancer treatment
- PMID: 26186888
- DOI: 10.1016/j.molmed.2015.06.005
Cell-penetrating peptides: strategies for anticancer treatment
Abstract
Cell-penetrating peptides (CPP) provide an efficient strategy for the intracellular delivery of bioactive molecules in various biomedical applications. This review focuses on recent advances in the use of CPPs to deliver anticancer therapeutics and imaging reagents to cancer cells, along with CPP contributions to novel tumor-targeting techniques. CPPs are now used extensively to deliver a variety of therapeutics, despite lacking cell specificity and having a short duration of action. Resolution of these shortcomings to enable increased cancer cell and/or tumor specificity could improve CPP-based drug delivery strategies, expand combined drug delivery possibilities, and strengthen future clinical applications of these peptides.
Keywords: anticancer; cell-penetrating peptide; elastin-like polypeptide; tumor targeting.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents.J Control Release. 2016 Oct 28;240:67-76. doi: 10.1016/j.jconrel.2015.10.040. Epub 2015 Oct 26. J Control Release. 2016. PMID: 26514292 Review.
-
Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.J Control Release. 2017 Mar 28;250:62-76. doi: 10.1016/j.jconrel.2017.02.006. Epub 2017 Feb 4. J Control Release. 2017. PMID: 28167286 Review.
-
Cell-penetrating peptides in protein mimicry and cancer therapeutics.Adv Drug Deliv Rev. 2022 Jan;180:114044. doi: 10.1016/j.addr.2021.114044. Epub 2021 Nov 10. Adv Drug Deliv Rev. 2022. PMID: 34774552 Review.
-
Cell penetrating peptides for tumor targeting.Curr Pharm Biotechnol. 2011 Aug;12(8):1166-82. doi: 10.2174/138920111796117391. Curr Pharm Biotechnol. 2011. PMID: 21470141 Review.
-
Recent advances of anti-cancer therapies including the use of cell-penetrating peptides.Curr Opin Pharmacol. 2019 Aug;47:8-13. doi: 10.1016/j.coph.2019.01.003. Epub 2019 Feb 13. Curr Opin Pharmacol. 2019. PMID: 30771730 Review.
Cited by
-
The influence of degree of labelling upon cellular internalisation of antibody-cell penetrating peptide conjugates.RSC Adv. 2022 Sep 28;12(43):27716-27722. doi: 10.1039/d2ra05274a. eCollection 2022 Sep 28. RSC Adv. 2022. PMID: 36320284 Free PMC article.
-
Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer.J Nanobiotechnology. 2016 Apr 22;14:33. doi: 10.1186/s12951-016-0185-x. J Nanobiotechnology. 2016. PMID: 27102372 Free PMC article.
-
Expanding the limits of the second genetic code with ribozymes.Nat Commun. 2019 Nov 8;10(1):5097. doi: 10.1038/s41467-019-12916-w. Nat Commun. 2019. PMID: 31704912 Free PMC article.
-
Cancer targeting peptides.Cell Mol Life Sci. 2019 Jun;76(11):2171-2183. doi: 10.1007/s00018-019-03061-0. Epub 2019 Mar 15. Cell Mol Life Sci. 2019. PMID: 30877335 Free PMC article. Review.
-
A Rational Design of α-Helix-Shaped Peptides Employing the Hydrogen-Bond Surrogate Approach: A Modulation Strategy for Ras-RasGRF1 Interaction in Neuropsychiatric Disorders.Pharmaceuticals (Basel). 2021 Oct 28;14(11):1099. doi: 10.3390/ph14111099. Pharmaceuticals (Basel). 2021. PMID: 34832880 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
